HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Abstract Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by McClellan, K. Articles by Alizadeh, H. Search for Related Content PubMed PubMed Citation Articles by McClellan, K. Articles by Alizadeh, H.

Effect of Steroids on Acanthamoeba Cysts and Trophozoites

¹ From the Department of Ophthalmology, University of Texas Southwestern Medical Center at Dallas.

	Abstract

Top Abstract Introduction Materials and Methods Results Discussion References

 
PURPOSE. Topical steroids are frequently used to control corneal inflammation and uveitis or is administered after surgery, to prevent corneal graft rejection. This study was undertaken to determine whether steroids could affect the pathogenicity of Acanthamoeba castellanii.

METHODS. The effect of dexamethasone phosphate on excystment, proliferation, and encystment of trophozoites and cysts of A. castellanii was examined in vitro. Cytolysis capacity of steroid-treated Acanthamoeba was quantified by a spectrophotometric assay, and plasminogen activators were measured by a fibrinolysis assay. The influence of steroid treatment on corneal infection in a Chinese hamster model of Acanthamoeba keratitis was examined in vivo.

RESULTS. Treatment of Acanthamoeba cysts with dexamethasone induced 4- to 10-fold increases in the number of trophozoites compared with untreated control cultures. Acceleration of trophozoite proliferation was observed when trophozoites were treated with dexamethasone. However, dexamethasone treatment did not affect encystment of Acanthamoeba trophozoites. Dexamethasone-treated trophozoites or cysts induced a significant cytopathic effect on corneal epithelial cells compared with untreated organisms. Supernatants collected from either dexamethasone-treated or untreated organisms failed to lyse corneal epithelial cells. Treatment of organisms with dexamethasone had no effect on production of plasminogen activators by Acanthamoeba trophozoites. Intramuscular injection of dexamethasone had a profound effect on the incidence, severity, and chronicity of keratitis. Keratitis in dexamethasone–treated hamsters was significantly more severe at all time points than in untreated animals (P < 0.05).

CONCLUSIONS. These findings indicate that exposure of Acanthamoeba trophozoites and cysts to dexamethasone increases the pathogenicity of the organisms. The results emphasize the importance of maintaining adequate amebicidal therapy if a topical steroid is used in the management of Acanthamoeba keratitis.

	Introduction

Top Abstract Introduction Materials and Methods Results Discussion References

 
Acanthamoeba keratitis in humans remains a challenging early diagnosis to confirm. In this corneal disease, the chronicity, tendency for recurrent inflammation, and severe pain help to distinguish the condition from bacterial or viral keratitis. The epidemiology of Acanthamoeba keratitis has been explained by its prevalence in contact lens wearers. Typically, waterborne organisms gain access to the corneal stroma after initial attachment to damaged corneal epithelium.^{1 2 3}

These infections have often been present for many weeks by the time the diagnosis is confirmed, and topical steroids have frequently been included in the therapy. Recrudescence of Acanthamoeba keratitis may occur after corneal transplantation if residual Acanthamoeba in the host peripheral cornea is exposed to steroids after surgery.⁴ Although steroids are frequently needed to control pain and inflammation in Acanthamoeba keratitis, their effects on trophozoites and cysts have not been investigated.^{5 6} It is therefore important to know whether such treatments have a direct effect on cysts and trophozoites or whether any effects of steroids on Acanthamoeba keratitis may be purely secondary to the resultant immunosuppression. Therefore, we wanted to determine whether steroids affect aspects of pathogenesis determined by the organism, including excystment, encystment, growth, cytolytic effects, and elaboration of plasminogen activators. We hypothesized that steroids would inhibit encystment of Acanthamoeba, while potentiating excystment, trophozoite growth, cytolysis, and elaboration of plasminogen activators.

	Materials and Methods

Top Abstract Introduction Materials and Methods Results Discussion References

 
A. castellanii Cultured Trophozoites and Cysts
The organism used in all experiments was a human ocular isolate of Acanthamoeba castellanii from the American Type Culture Collection (ATCC; 30868; Rockville, MD). Trophozoites were maintained in axenic culture at 35°C in peptone-yeast-glucose (PYG) medium in test tubes, as described previously.^{7 8} Acanthamoeba cysts were prepared by culturing trophozoites on non-nutrient agar plates without bacteria at 35°C for 1 week. At the end of 1 week, cysts were examined, and the surfaces of the agar plates were washed with 10 ml Page’s saline and scraped with a tissue scraper. Double-walled cysts with a wrinkled exocyst and an average diameter of 19 µm were produced and stored in Page’s saline until use.

Excystment of Dexamethasone Phosphate–Treated A. castellanii Cysts In Vitro
A. castellanii cysts (2 x 10⁵/ml) were incubated for 24 hours at 35°C, in 5 ml PYG medium containing 10, 100, or 400 µg/ml dexamethasone phosphate (Sigma Chemical Co., St Louis, MO). Trophozoites were then counted by a hemocytometer. Each culture was reincubated with the original concentration of dexamethasone, and trophozoites were counted daily for an additional 6 days. The control cultures were A. castellanii cysts (2 x 10⁵/ml) incubated for 24 hours at 35°C in 5 ml PYG medium without dexamethasone. Experimental tubes for each dexamethasone concentration and control were set up in duplicate.

Proliferation of Dexamethasone-Treated A. castellanii Trophozoites In Vitro
A. castellanii trophozoites (2 x 10⁴/ml) were incubated for 24 hours at 35°C, in 5 ml PYG medium containing 10, 100, and 400 µg/ml dexamethasone, at concentrations ranging from 10 to 400 µg/ml. Trophozoites were then counted by a hemocytometer. Each culture was reincubated with the original concentration of dexamethasone and trophozoites were counted daily for an additional 6 days. The control cultures were A. castellanii trophozoites (2 x 10⁴/ml) incubated at 35°C in 5 ml PYG medium without dexamethasone. Experimental tubes for each dexamethasone concentration and control were set up in duplicate.

Encystment of Dexamethasone-Treated A. castellanii Trophozoites In Vitro
A. castellanii trophozoites (2 x 10⁴/ml) were incubated for 24 hours at 35°C, in 5 ml PYG medium containing 10, 100, and 400 µg/ml dexamethasone. Trophozoites were then counted and the tube containing 1 x 10⁵ trophozoites was centrifuged at 1000g for 5 minutes and the pellet suspended in 0.2 ml Page’s saline. The trophozoite suspensions were cultured on non-nutrient agar at 35°C, as described elsewhere.¹ Encystment was determined after incubation for 2, 4, and 24 hours, then daily for 6 days. Cysts and trophozoites were counted in each of 10 microscopic fields. Control cultures consisted of trophozoites incubated without dexamethasone. All experiments and controls were performed in duplicate. The percentage of encysted organisms in experimental and control plates was compared at each time point.

Cell Cultures
Human corneal epithelial (HCE) cells were kindly provided by Sally L. Ward (Gillette Medical Evaluation Laboratories, Gaithersburg, MD), and cultured in KGM (Clonetics, Irvine, CA) at 37°C in 5% CO₂, as described previously.⁹

Cytopathic Effect Assay with HCE Cells
HCE cells were chosen as target cells for the cytopathic effect (CPE) assay for their demonstrated susceptibility to lysis by A. castellanii trophozoites and reliable propagation in vitro.² The CPE assay was performed as described previously.¹⁰ Briefly, HCE cell suspensions were seeded into flat-bottomed 96-well microtiter plates (1 x 10⁵ cells/well) and cultured until they became confluent. A. castellanii trophozoites or cysts were incubated for 24 hours at 35°C in 1 ml PYG containing 10, 100, and 400 µg/ml dexamethasone. Trophozoites were then counted by a hemocytometer and 2 x 10⁵ added to the confluent cultures of HCE cells. Wells containing HCE cells alone or A. castellanii trophozoites or cysts with dexamethasone at 10, 100, and 400 µg/ml or without dexamethasone, served as control cultures. After incubation, all wells were washed three times with PYG and stained with Giemsa stain. The remaining contents were solubilized in 0.1 ml 5% sodium dodecyl sulfate (SDS) in phosphate-buffered saline (pH 7.2; Sigma Chemical Co.) and transferred to a new 96-well plate, and the density of the residual epithelial cells was quantified by determining the optical density (OD) at 590 nm on a microplate reader (Molecular Devices Corp., Menlo Park, CA). Results were expressed as mean OD ± SD for each group. All assays were performed in triplicate. The spectrophotometric results were confirmed by inspection of the wells with compound microscopy.

Acanthamoeba Supernatants
For assay testing of cytolytic capability, supernatants were collected from A. castellanii trophozoites that had been incubated for 24 hours with dexamethasone at 10, 100, and 400 µg/ml. Supernatants were tested for cytolytic activity by adding 0.1 ml supernatant to wells containing confluent HCE cells in the 96-well plates. Control wells contained HCE cells alone or untreated A. castellanii. The CPE was quantified as described earlier.

Fibrin Clot Lysis Assay
Fibrinogen-agarose overlays were prepared by mixing 15 mg/0.1 ml fibrinogen (F-8630; fraction 1, type I-S from bovine plasma; Sigma Chemical Co.) in 0.1 M Tris-HCl (pH 7.6) with 20 mg/0.1 ml low-melting-temperature agarose (Sigma Chemical Co.), prepared in the same buffer at 40°C. After adding 1.0 IU thrombin (Sigma Chemical Co.), the mixture was poured between two glass plates separated by a 2.5-mm spacer.¹¹ Wells 5 mm in diameter were cut into the fibrin clot and the assay performed by adding 10 µl supernatant from trophozoites treated with dexamethasone at doses of 10, 100, or 400 µg/ml or by adding untreated trophozoites to each well and incubating at 37°C. PYG medium without trophozoites was used as the control. Clots without plasminogen were included in all experiments to control for plasminogen-independent fibrinolysis.

The diameter of the clear zone in the clot was measured after incubation at 37°C for 2, 3, 5, and 8 hours. By using human tissue plasminogen activator (tPA; American Diagnostica, Greenwich, CT) as a standard, a linear relationship between the diameter of the clear zones and the tPA concentration was established as described previously.¹²

Animals
Chinese hamsters were purchased from Cytogen Research and Development, Inc. (West Roxbury, MA) and used at ages 4 to 6 weeks. The corneas were examined before experimentation to exclude animals with any preexisting corneal disease. All animals were handled in accordance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research.

Contact Lens Preparation
Contact lenses were made 3.0 mm in diameter from dialysis membrane tubing (Spectra/Por; Spectrum Medical Industries, Los Angeles, CA) and heat sterilized. Dialysis tubing contact lenses were incubated for 24 hours at 35°C with A. castellanii in 200 µl PYG containing 3 x 10⁶/well (50% trophozoites, 50% cysts) in 96-well microtiter plates (Costar, Cambridge, MA).

In Vivo Corneal Infection
Acanthamoeba keratitis was established in the cornea of the Chinese hamster, as described previously, by application of an A. castellanii-laden contact lens to an abraded corneal surface.⁷ Chinese hamsters were anesthetized with ketamine (100 mg/kg) given intramuscularly (IM; Ketaset; Ft. Dodge Laboratories, Ft. Dodge, IA) and supplemented with topical proparacaine (Alcon Inc., Humacao, Puerto Rico). A contact lens laden with A. castellanii was placed over the abraded cornea of one eye and the eyelids closed by central tarsorrhaphy with a 6-0 suture (Ethilon; Ethicon, Inc., Somerville, NJ). The contact lenses were removed 6 days after infection, and the corneas were observed under a dissecting microscope for clinical signs of keratitis. Animals were observed on days 7, 14, 21, and 35 after infection. Keratitis was scored on a scale of 0 to 5, according to corneal infiltration, corneal neovascularization, and corneal ulceration. Disease severity was recorded as: 0, no disease; 1, less than 10% of the cornea involved; 2, 10% to 25% involved; 3, 25% to 50%; 4, 50% to 75%; and 5, 75% to 100%, as described previously.⁷ Animals graded with a score of at least 1.0 for any parameter were considered infected. Acanthamoeba keratitis in Chinese hamsters resolved at approximately day 21, at which time corneal opacity, stromal necrosis, and inflammation had cleared and corneal epithelium was intact. Acanthamoeba trophozoites and cysts were not present on histologic examination of corneas in which keratitis had resolved.

Systemic Dexamethasone
Dexamethasone (0.1 mg/100 µl of saline) was administered IM daily for 3 days to 10 Chinese hamsters, beginning 24 hours after the contact lens was applied. A control group of 10 Chinese hamsters received 100 µl IM saline.

Statistical Analysis
Student’s t-test was used to determine the significance of the differences between experimental and control groups. Clinical severity scores were analyzed by Mann-Whitney test. P < 0.05 was considered statistically significant.

	Results

Top Abstract Introduction Materials and Methods Results Discussion References

 
Excystment of A. castellanii
In Acanthamoeba keratitis, cysts are frequently found deep in the corneal stroma. Topical application of steroids after corneal transplantation may increase the risk of recurrence of Acanthamoeba keratitis by inducing the excystment of the organisms. The effect of dexamethasone on the excystment of A. castellanii cysts was evaluated in vitro. The number of trophozoites in dexamethasone-treated cysts exceeded that in untreated control cultures by two- to sixfold for all concentrations of dexamethasone after 24 hours’ incubation (Fig. 1) . A dexamethasone concentration equal to or greater than 100 µg/ml produced the greatest number of trophozoites; above this concentration the excystment response was uniform. After 48 hours’ incubation, dexamethasone-treated cysts continued to produce three times the number of trophozoites present in untreated control cultures (P < 0.05). Trophozoites in treated cultures exceeded those in control at concentrations equal to or greater than 10 µg/ml dexamethasone. The number of trophozoites recovered from the dexamethasone-treated group at concentrations of 100 and 400 µg/ml was significantly higher than in control cultures after 72 hours’ incubation (P < 0.05). However, no significant differences were observed in the number of trophozoites between dexamethasone-treated and untreated control cultures after 96 hours’ incubation (Fig. 1) .

View larger version (43K): [in this window] [in a new window]   Figure 1. Effect of dexamethasone on excystment of A. castellanii. A. castellanii cysts (1 x 106) were incubated for 24 hours at 35°C in 5 ml PYG medium containing 10, 100, or 400 µg/ml dexamethasone. Each culture was reincubated with the original concentration of dexamethasone, and trophozoites were counted daily for a further 4 days. Results are expressed as the mean number of trophozoites per milliliter ± SD. *Significantly different from untreated control cultures (P < 0.05).

View larger version (49K): [in this window] [in a new window]   Figure 2. Effect of dexamethasone on the excystment rates of A. castellanii cysts. A. castellanii cysts (1 x 106/ml) were treated with 10, 100, or 400 µg/ml dexamethasone for 24 hours at 35°C. Each culture was reincubated with the original concentration of dexamethasone, and cysts were counted daily for 4 consecutive days. Results are expressed as a percentage of the cysts in the culture. Error bars indicate SD. *Significantly different from untreated control cultures (P < 0.05).

Trophozoite proliferation was accelerated by dexamethasone at concentrations of 100 and 400 µg/ml after 24 hours of continuous exposure (Fig. 3) . With 48 hours of continuous exposure to dexamethasone at concentrations greater than or equal to 10 µg/ml, trophozoite proliferation was significantly greater than that in untreated control cultures (P < 0.05). This positive effect on trophozoite growth was maintained after 72 hours of continuous dexamethasone exposure and was effective at concentrations of dexamethasone greater than or equal to 10 µg/ml (P < 0.05). The effect of steroid treatment of trophozoites was lost after 96 hours’ incubation, with no significant difference in number of trophozoites compared with untreated control cultures (Fig. 3) .

View larger version (46K): [in this window] [in a new window]   Figure 3. Effect of dexamethasone on proliferation of A. castellanii trophozoites. A. castellanii trophozoites (1 x 105) were incubated for 24 hours at 35°C in 5 ml PYG medium containing 10, 100, or 400 µg/ml dexamethasone. Each culture was reincubated with the original concentration of dexamethasone, and trophozoites were counted daily for an additional 4 days. Results are expressed as the mean number of trophozoites per milliliter ± SD. *Significantly different from untreated control cultures (P < 0.05).

View larger version (29K): [in this window] [in a new window]   Figure 4. Effect of dexamethasone on CPE mediated by A. castellanii trophozoites. HCE cell monolayers were incubated for 48 hours with trophozoites (1 x 105) in medium with or without 10, 100, or 400 µg/ml dexamethasone (A), or with trophozoites that were pretreated with dexamethasone for 48 hours before addition to HCE cells (B). CPE was assessed 48 hours later. Negative control cultures consisted of monolayers cultured in media with dexamethasone or without trophozoites. Monolayers were washed and stained with Giemsa stain, and CPE was assessed spectrophotometrically. *Significantly different from untreated control cultures (P < 0.05).

View larger version (53K): [in this window] [in a new window]   Figure 5. Cytolytic activity of supernatants from A. castellanii trophozoites treated with dexamethasone. A. castellanii trophozoites were treated for 24 hours in PYG medium with or without 10, 100, or 400 µg/ml dexamethasone. After 24 hours’ incubation, the culture supernatants were removed and then added to HCE cells, and the CPE was assessed 48 hours later. Negative control cultures consisted of cell monolayers cultured in medium without trophozoites. Monolayers were washed and stained with Giemsa stain, and CPE was assessed spectrophotometrically. The differences between experimental groups were insignificant (P > 0.05).

HCE cells were incubated for 72 hours with A. castellanii cysts (2.5 x 10⁵) in medium with or without 10, 100, and 400 µg/ml dexamethasone. In other experiments, cysts were pretreated with dexamethasone for 72 hours and were then applied to HCE cells. The CPE was measured 72 hours later, as described in the Methods section. Pretreatment of cysts with dexamethasone did not produce significant CPE. However, cysts incubated with dexamethasone for 72 hours induced significant cytolysis of HCE cells (Fig. 6) . Dexamethasone at a concentration of 100 µg/ml produced more than 33% cyst-associated cytolysis (P < 0.05). Moreover, incubation in different concentrations of dexamethasone alone did not affect HCE cell viability. The results indicate that the presence of dexamethasone had a profound effect on cyst-associated cytolysis. However, the supernatant collected from cysts exposed to different concentrations of dexamethasone did not induce significant cytolysis (data not shown). We conclude that the increased CPE that follows cyst treatment with steroids is due to accelerated excystment and enhanced proliferation of trophozoites, which are the actual mediators of CPE.

View larger version (34K): [in this window] [in a new window]   Figure 6. Effect of dexamethasone on CPE associated with A. castellanii cysts. HCE cells were either incubated for 72 hours with A. castellanii cysts (2 x 105) in medium with and without 10, 100, or 400 µg/ml dexamethasone (A) or cysts were pretreated with dexamethasone for 48 hours before addition to HCE cells (B). CPE was assessed 72 hours later. Negative control cultures consisted of cell monolayers cultured in medium with dexamethasone or without cysts. The monolayers were washed and stained with Giemsa stain, and CPE was assessed spectrophotometrically. *Significantly different from untreated control cultures (P < 0.05).

View larger version (56K): [in this window] [in a new window]   Figure 7. Levels of Acanthamoeba plasminogen activator (APA) produced by trophozoites treated with dexamethasone. Trophozoites were incubated for 24 hours in PYG medium with or without 10, 100, or 400 µg/ml dexamethasone. After 24 hours’ incubation, the supernatants were collected, and APA activity was measured by radial diffusion in the fibrin agarose clot. APA activity is expressed in IU per milligram relative to a tissue plasminogen standard. The differences between trophozoites treated with dexamethasone and untreated organisms were insignificant (P > 0.05).

Intramuscular injection of dexamethasone had a profound effect on the incidence, severity, and chronicity of keratitis. The incidence of infection in untreated animals was 89%, but increased to 100% in dexamethasone-treated animals (Fig. 8) . The increased rates of infection were maintained throughout the period of observation. However, dexamethasone treatment did not accelerate the onset of keratitis.

View larger version (14K): [in this window] [in a new window]   Figure 8. The effect of systemic dexamethasone on Acanthamoeba keratitis in Chinese hamsters. Animals (n = 10) were injected IM with 1 mg/ml dexamethasone in 100 µl saline. The animals were treated with dexamethasone daily for 3 days, beginning 24 hours after Acanthamoeba-laden contact lenses were applied. A control group of 10 Chinese hamsters received 100 µl saline IM. Infected lenses were removed after 6 days, and the corneas were scored for percentage of infection (A) or clinical severity (B) for the period indicated. *Significantly different from control (saline injected) animals (P < 0.05).

	Discussion

Top Abstract Introduction Materials and Methods Results Discussion References

 
Although topical steroids have been consistently included in therapy for Acanthamoeba keratitis, their effects on the organism have not been documented. The existence of two forms of Acanthamoeba, trophozoites and cysts, affords the organism maximal environmental adaptation and so assists in its survival.^{14 15 16 17 18}

The Acanthamoeba trophozoite is capable of initiating these corneal infections if there is an epithelial defect.⁷ Acanthamoebae attach to corneal epithelium through a mannose-specific surface receptor.¹⁹ Adherent acanthamoebae secrete soluble factors that dissociate and kill corneal epithelial cells.^{20 21 22} Apoptosis of epithelial cells may also facilitate corneal penetration of the organism.^{13 23} Acanthamoebae secrete collagenase, as well as a series of proteases that enable it to penetrate deep into the corneal stroma.^{12 24 25 26}

The Acanthamoeba cyst is the dormant form of the organism, produced by inhibition of DNA synthesis and glucose starvation.^{27 28} Cysts are often found deep in the corneal stroma in established Acanthamoeba keratitis.^{3 5 6 7 8 10 11 29}

The susceptibility of both trophozoites and cysts to killing by polyhexamethylene biguanide, chlorhexidine, and propamidine isethionate has been confirmed, and these agents remain the mainstay of amebicidal therapy.^{30 31 32 33 34 35} Although steroids are frequently needed to control pain and inflammation in Acanthamoeba keratitis, their effect on trophozoites and cysts has not been previously investigated.^{5 6}

These experiments show for the first time that exposure of Acanthamoeba cysts to dexamethasone promotes excystment of the organism. After 24 hours of dexamethasone exposure, the number of trophozoites significantly exceeded that in untreated control cultures, at all concentrations of dexamethasone. This effect was maintained during an additional 24 hours of exposure, and rates of excystment were similar for all concentrations of the steroid. Significant reduction in the number of cysts exposed to all concentrations of dexamethasone was observed in the culture at 2, 3, and 4 days after incubation. These results indicate that use of topical steroids at even a minimal dose promotes an increase in the number of trophozoites produced by excystment in corneal stroma while any cysts remain. This work emphasizes the clinical importance of the maintenance of an adequate dose of amebicidal drugs if steroids are considered necessary to control pain or inflammation in Acanthamoeba keratitis.

The greater excystment of Acanthamoeba at higher steroid concentrations should be considered when using steroid therapy as prophylaxis against corneal graft rejection after penetrating keratoplasty (PK). Cure of Acanthamoeba keratitis has not always been achieved with PK.^{29 36 37 38} Risk of recurrent Acanthamoeba keratitis has been considered greatest in the post-PK period.^{1 39} Our results indicate that residual cysts in the host peripheral cornea may undergo excystment when exposed to higher doses of steroids. Use of the minimum necessary dose of topical steroid and continuation of adequate doses of amebicidal therapy are therefore most important in the management of these corneal grafts.

Dexamethasone also stimulated the growth of trophozoites, with all steroid concentrations producing proliferation of the organism that exceeded that in control cultures, after 48 hours of exposure. This effect was maintained through 72 hours. These results mean that with continuing exposure to steroids, the number of Acanthamoeba trophozoites can be expected to increase significantly in the cornea by two mechanisms: excystment and accelerated multiplication of trophozoites.

Use of topical steroid, unaccompanied by amebicidal therapy, would be expected to produce proliferation of Acanthamoeba trophozoites. This is particularly important in patients in which the diagnosis of Acanthamoeba keratitis has not been made and steroids are being used in an attempt to control corneal inflammation and uveitis. The resultant proliferation of the invasive form of the organism exposes patients to the risk of significantly greater corneal destruction through an increase in organism load. This explains the observation that early diagnosis and appropriate therapy with cationic antiseptics, together with propamidine isethionate and neomycin, provides the greatest likelihood of a medical cure.^{40 41}

It has been observed that late diagnosis of Acanthamoeba keratitis is a cause of failure of medical treatment, whereas use of topical steroids is not.¹⁷ However, in this study we also recognized that patients treated with topical steroids require a significantly longer duration of amebicidal therapy.¹⁷ Our study provides evidence that dexamethasone increases the number of trophozoites through excystment and proliferation. Increasing the corneal load of this invasive form of Acanthamoeba by use of topical steroid would be expected to prolong the infection. Clinical studies suggest that exposure to steroids does not promote resistance of the organism to amebicidal therapy.¹⁷

The effect of steroids on free-living amoebae demonstrates some species specificity. Systemic prednisolone has been shown to increase mortality rates twofold among albino mice infected intranasally with Naeglaria spp., compared with mice inoculated with Acanthamoeba spp.⁴² The Naeglaria spp.–infected mice had more histopathologic evidence of brain necrosis and meningeal inflammation than did those infected with Acanthamoeba spp.

Our results show that dexamethasone failed to influence rates of encystment of trophozoites. In the presence of an increased trophozoite load within the cornea, produced by accelerated excystment and trophozoite growth, maintenance of encystment rates of Acanthamoeba preserves the pathogenicity of the organism. Thus, the active trophozoites have maximum time to cause corneal damage through inflammation and epithelial and stromal lysis until encystment brings more quiescent disease.

Binding to corneal cells is the first step in the pathogenic cascade of Acanthamoeba keratitis and is followed by cytolysis of the corneal epithelial cells. These events are potentiated by the trophozoite load in the cornea, which plays an important role in the pathogenicity of the disease. We hypothesized that exposure of Acanthamoeba to dexamethasone increases Amoeba-mediated cytolysis. The present results suggest that pretreatment of organisms with dexamethasone did not produce any significant cytolysis. However, the presence of dexamethasone in the medium was necessary for organism-mediated cytolysis. We suspect that dexamethasone stimulates the cytolytic machinery of acanthamoebae by activating the organisms to release cytolytic factors. Supernatants from trophozoites treated with dexamethasone did not induce significant CPE on corneal epithelial cells, compared with untreated organisms. However, the results suggest that prolonged exposure to dexamethasone induces excystment and proliferation of organisms, which in turn potentiates trophozoite-mediated cytolysis. These results imply that under these conditions, Acanthamoeba trophozoites are capable of inducing more damage to corneal epithelial cells if stimulated with steroids. We and others have shown that Acanthamoeba spp. can destroy cells by either direct or indirect cytolysis of target cells.^{10 13 23 25} The exact mechanisms involved in trophozoite-mediated cytolysis are not known, but we have shown that destruction of target cells can occur by apoptosis.²³

Characterization of molecules that induce excystment of Acanthamoeba by dexamethasone will hopefully yield further insights into the pathogenesis of Acanthamoeba keratitis. In the present study we examined the effect of steroids on A. castellanii trophozoites and cysts only. However, it would be interesting to compare the effect of steroids on morphogenesis of other Acanthamoeba strains.

Serine proteases play an important role in a broad array of biological processes, including tumor invasion, metastasis, and tissue invasion by metazoan parasites.^{43 44} We have demonstrated the close association between the elaboration of plasminogen activators in vitro and the pathogenic potential of human ocular isolates of Acanthamoeba spp.¹³ Because the pathogenesis of Acanthamoeba keratitis is dependent on the capacity of the organism to penetrate the corneal epithelium and enter the underlying stromal matrix, we hypothesized that dexamethasone induces trophozoites to secrete more plasminogen activators that increase tissue invasion and contribute to the pathogenesis of the disease. The results of the present study indicate that A. castellanii produced plasminogen activators, as previously reported. However, the results also show that dexamethasone-treated trophozoites secreted similar quantities of plasminogen activators compared with untreated trophozoites. Thus, it seems that the enhanced cytolysis of epithelial cells by dexamethasone-treated Acanthamoeba is not due to increased elaboration of plasminogen activators. It is possible that other enzymes such as collagenase, metalloproteinase, cysteine proteases, and elastases that are constitutively produced by pathogenic acanthamoebae are involved in dexamethasone-treated trophozoite cytolysis.^{24 25 26 45 46}

Innate immune responses to acanthamoebae are considered the most important defenses against the organism. The histopathology of established Acanthamoeba keratitis shows macrophages, neutrophils, and few lymphocytes, indicating that adaptive immunity does not drive the cellular response to the organism. Macrophages predominate in experimental Acanthamoeba keratitis.^{2 10 12 13 30 32 47 48} It is known that steroids can suppress the host immune and inflammatory responses such as macrophages and neutrophils that play and important role in Acanthamoeba keratitis.^{49 50 51 52 53 54 55 56 57 58}

Our results show that Chinese hamsters treated with systemic dexamethasone are more likely to have Acanthamoeba keratitis and that the resultant infection is more severe and fails to resolve. Systemic dexamethasone downregulates the innate immune system through inhibition of neutrophil chemotaxis and neutrophil and macrophage activation. Thus, the effects of steroid-induced severe Acanthamoeba infection in the Chinese hamster are consistent with previous findings that macrophage depletion induces chronic Acanthamoeba keratitis.⁵⁴ In our in vitro studies, exposure to dexamethasone increased the number of trophozoite through excystment and growth. Although systemic steroid may be expected to have less direct effect on the pathogenicity of acanthamoebae within the corneal stroma than topical steroids, it is possible that such steroids may reach the cornea through limbal blood vessels with increased permeability due to inflammation. Acanthamoeba infections can ultimately be cured only by elimination of the organism from the cornea. These results indicate that effective doses of amebicidal therapy should be continued while patients are receiving any concurrent topical steroid therapy to control the inflammatory complications of Acanthamoeba keratitis.

	Footnotes

 
² Present affiliation: Department of Ophthalmology, University of Sydney, Australia.

Supported in part by Grants EY09756 from the National Eye Institute and an unrestricted grant from Research to Prevent Blindness. KM was supported by a Traveling Fellowship from the Royal Australian College of Ophthalmologists.

Submitted for publication March 27, 2001; revised June 29, 2001; accepted July 16, 2001.

Commercial relationships policy: N.

The publication costs of this article were defrayed in part by page charge payment. This article must therefore be marked "advertisement" in accordance with 18 U.S.C. 1734 solely to indicate this fact.

Corresponding author: Hassan Alizadeh, Department of Ophthalmology, University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390-9057. hassan.alizadeh{at}utsouthwestern.edu

	References

Top Abstract Introduction Materials and Methods Results Discussion References

 

1. Alizadeh, H, Niederkorn, JY, McCulley, JP (1996) Acanthamoeba keratitis Pepose, JS Holland, GN Willhelmus, KR eds. Ocular infection and Immunity ,1062-1071 Mosby St. Louis.
2. Niederkorn, JY, Alizadeh, H, Leher, H, McCulley, JP (1999) The pathogenesis of Acanthamoeba keratitis Microbes Infect 1,437-443[Medline][Order article via Infotrieve]
3. Mathers, WD, Sutphin, JE, Folberg, R, Meier, PA, Wood, RP, Elgin, RG (1996) Outbreak of keratitis presumed to be caused by Acanthamoeba Am J Ophthalmol 121,129-142[Medline][Order article via Infotrieve]
4. Illingworth, CD, Cook, SD (1998) Acanthamoeba keratitis Surv Ophthalmol 42,493-508[Medline][Order article via Infotrieve]
5. Wright, P, Warhurst, D, Jones, BR (1985) Acanthamoeba keratitis successfully treated medically Br J Ophthalmol 69,778-782[Abstract/Free Full Text]
6. Larkin, DFP, Kilvington, S, Dart, JKG (1992) Treatment of Acanthamoeba keratitis with polyhexamethylene biguanide Ophthalmology 99,185-189[Medline][Order article via Infotrieve]
7. Van Klink, F, Alizadeh, H, He, Y, et al (1993) The role of contact lenses, trauma and Langerhans’ cells in a Chinese hamster model of Acanthamoeba keratitis Invest Ophthalmol Vis Sci 34,1937-1944[Abstract/Free Full Text]
8. Silvany, RE, Dougherty, JM, McCulley, JP, Wood, TS, Bowman, RW, Moore, MB (1990) The effect of currently available contact lens disinfection systems on Acanthamoeba castellanii and Acanthamoeba polyphaga Ophthalmology 97,286-290[Medline][Order article via Infotrieve]
9. Kahn, CR, Young, E, Lee, IH, Rhim, JS (1993) Human corneal epithelial primary cultures and cell lines with extended life span: in vitro model for ocular studies Invest Ophthalmol Vis Sci 34,3429-3441[Abstract/Free Full Text]
10. Larkin, DFP, Berry, M, Easty, DL (1991) In vitro corneal pathogenicity of Acanthamoeba Eye 5,560-568
11. Levin, EG, Loskutoff, DJ (1982) Cultured bovine endothelial cells produce both urokinase and tissue-type plasminogen activators J Cell Biol 94,631-636[Abstract/Free Full Text]
12. Mitra, MM, Alizadeh, H, Gerard, RD, Niederkorn, JY (1995) Characterization of a plasminogen activator produced by Acanthamoeba castellanii Mol Biochem Parasitol 73,157-164[Medline][Order article via Infotrieve]
13. Van Klink, F, Alizadeh, H, Stewart, GL, et al (1992) Characterization of the pathogenic potential of a soil isolate and an ocular isolate of Acanthamoeba castellanii in relation to Acanthamoeba keratitis Curr Eye Res 12,1207-1220
14. Horsburgh, B, Hirst, LW, Carey, T, Whitby, RM, Nimmo, G, Stallard, K. (1991) Steroid sensitive Acanthamoeba keratitis Aust NZ J Ophthalmol 19,349-351[Medline][Order article via Infotrieve]
15. Rabinovitch, T, Weissman, SS, Ostler, HB, Sheppard, JD, Teikari, J. (1991) Acanthamoeba keratitis: clinical signs and analysis of outcome (Abstract) Rev Infect Dis 13,S427
16. Nakagawa, H, Kazami, N, Izai, K, et al (1993) Two cases of early Acanthamoeba keratitis Nippon Ganka Gakkai Zasshi 97,544-550[Medline][Order article via Infotrieve]
17. Park, DH, Palay, DA, Daya, SM, Stulting, RD, Krachmer, JH, Holland, EJ (1997) The role of topical corticosteroids in the management of Acanthamoeba keratitis Cornea 16,277-283[Medline][Order article via Infotrieve]
18. Visvesvara, GS, Stehr-Green, J. (1990) Epidemiology of free-living ameba infections J Protozool 37,25S-33S[Medline][Order article via Infotrieve]
19. Yang, Z, Cao, Z, Panjwani, N. (1997) Pathogenesis of Acanthamoeba keratitis: carbohydrate mediated host-parasite interactions Infect Immun 65,439-445[Abstract]
20. Moore, MB, Ubelaker, JE, Martin, JH, et al (1991) In vitro penetration of human corneal epithelium by Acanthamoeba castellanii: a scanning and transmission electron microscopic study Cornea 10,291-298[Medline][Order article via Infotrieve]
21. Mattana, A, Bennardini, F, Usai, S, Fiori, PL, Franconi, F, Cappuccinelli, P. (1997) Acanthamoeba castellanii metabolites increase intracellular calcium level and cause cytotoxicity in Wish cells Microb Pathol 23,85-93
22. Leher, H, Silvany, R, Alizadeh, H, Huang, J, Niederkorn, JY (1998) Mannose induces the release of cytopathic factors from Acanthamoeba castellanii Infect Immun 66,5-10[Abstract/Free Full Text]
23. Alizadeh, H, Pidherney, M, McCulley, JP, Niederkorn, JY (1994) Apoptosis as a mechanism of cytolysis of tumor cells by a pathogenic free-living ameba Infect Immun 62,1298-1303[Abstract/Free Full Text]
24. He, Y-G, Niederkorn, JY, McCulley, JP, et al (1990) In vivo and in vitro collagenolytic activity of Acanthamoeba castellanii Invest Ophthalmol Vis Sci 31,2235-2240[Abstract/Free Full Text]
25. Cao, Z, Jefferson, DM, Panjwani, N. (1998) Role of carbohydrate-mediated adherence in cytopathogenic mechanisms of Acanthamoeba J Biol Chem 25,15838-15845
26. Mitro, K, Bhagavathiamai, A, Zhou, OM, et al (1994) Partial characterization of the proteolytic secretions of Acanthamoeba polyphaga Exp Parasitol 78,377-385[Medline][Order article via Infotrieve]
27. Neff, RJ, Neff, RH (1969) The biochemistry of amoebic encystment Symp Soc Exp Biol 23,51-81[Medline][Order article via Infotrieve]
28. Byers, TJ, Atkins, RA, Maynard, BJ, Lafleen, RA, Martin, SM (1980) Rapid growth of Acanthamoeba in defined media; induction of encystment by glucose-acetate starvation J Protozool 27,216-219[Medline][Order article via Infotrieve]
29. Bacon, AS, Frazer, DG, Dart, JK, Matheson, M, Ficker, LA, Wright, P. (1993) A review of 72 consecutive cases of Acanthamoeba keratitis Eye 7,719-725
30. Garner, A. (1993) Pathogenesis of Acanthamoeba keratitis: hypothesis based on histological analysis of 30 cases Br J Ophthalmol 77,366-370[Abstract/Free Full Text]
31. Dougherty, PJ, Binder, PS, Mondino, BJ, Glasgow, BI (1994) Acanthamoeba sclerokeratitis Am J Ophthalmol 117,475-479[Medline][Order article via Infotrieve]
32. Kremer, I, Cohen, EJ, Eagle, RC, Jr, Udell, I, Laibson, PR (1994) Histopathological evaluation of stromal inflammation in Acanthamoeba keratitis CLAO J 20,45-48[Medline][Order article via Infotrieve]
33. Pfister, DR, Cameron, JD, Krachmer, JA, Holland, EJ (1996) Confocal microscopy findings in Acanthamoeba keratitis Am J Ophthalmol 121,119-128[Medline][Order article via Infotrieve]
34. Duguid, IG, Dart, JK, Morlet, N, Allan, BD, Matheson, M, Ficker, L, Tuft, S. (1997) Outcome of Acanthamoeba keratitis treated with polyhexamethyl biguanide and propamidine Ophthalmology 104,1587-1592[Medline][Order article via Infotrieve]
35. Ashton, N, Stamm, W. (1975) Amoebic infection of the eye: a pathological report Trans Ophthalmol Soc UK 95,214-220[Medline][Order article via Infotrieve]
36. Peterson, RJ, Smith, ME, Pepose, JS (1990) Recurrent Acanthamoeba keratitis following penetrating keratoplasty Arch Ophthalmol 108,1482-1483[Medline][Order article via Infotrieve]
37. Ficker, LA, Kirkness, C, Wright, P. (1993) Prognosis for keratoplasty in Acanthamoeba keratitis Ophthalmology 100,105-110[Medline][Order article via Infotrieve]
38. Hargrave, SL, McCulley, JP, Huseini, Z. (1999) Results of a trial of combined propamidine isethionate and neomycin therapy for Acanthamoeba keratitis. Brolene study Ophthalmology 106,952-957[Medline][Order article via Infotrieve]
39. McCulley, JP, Alizadeh, H, Niederkorn, JY (1995) Acanthamoeba keratitis CLAO J 21,73-80[Medline][Order article via Infotrieve]
40. Illingworth, CD, Cook, SD, Karabatsas, CH, Easty, DL (1995) Acanthamoeba keratitis: risk factors and outcome Br J Ophthalmol 79,1078-1082[Abstract/Free Full Text]
41. Lindquist, TD (1998) Treatment of Acanthamoeba keratitis Cornea 17,11-16[Medline][Order article via Infotrieve]
42. el-Fakahany AF, ,, Fahmy RR, ,, Mohamed AS. , (1997) Free-living amoebae as opportunistic parasites in immunocompromised hosts J Egypt Soc Parasitol 27,515-527[Medline][Order article via Infotrieve]
43. Danø, K, Anderson, PA, Grondahl-Hansen, J, Kristensen, P, Nielsen, LS, Skriver, L. (1985) Plasminogen activators, tissue degradation, and cancer Adv Cancer Res 44,139-266[Medline][Order article via Infotrieve]
44. McKerrow, JH, Newport, G, Fishelson, Z. (1991) Resent insight into structure and function of a larval proteinase involved in the host infection by a multicellular parasite Pro Soc Exp Biol Med 197,119-124[Medline][Order article via Infotrieve]
45. Hadas, E, Mazur, T. (1993) Proteolytic enzymes of pathogenic and non-pathogenic strains of Acanthamoeba spp Trop Med Parasitol 44,197-200[Medline][Order article via Infotrieve]
46. Ferrante, A, Bates, EJ (1988) Elastase in the pathogenic free-living amoebae Naegleria and Acanthamoeba spp Infect Immun 56,3320-3321[Abstract/Free Full Text]
47. Mathers, W, Steverns, G, Jr, Rodriguez, M, et al (1987) Immunopathology and electron microscopy of Acanthamoeba keratitis Am J Ophthalmol 103,626-635[Medline][Order article via Infotrieve]
48. Garner, A. (1988) Pathology of acanthamoebic infection Cavanagh, HD eds. The Cornea: Transactions of the World Congress on the Cornea, III ,535-539 Raven Press New York.
49. Marciano-Cabral, F, Toney, DM (1998) The interaction of Acanthamoeba spp. with activated macrophages or with macrophage cell lines J Eukaryot Microbiol 45,452-458[Medline][Order article via Infotrieve]
50. Stewart, GL, Kim, I, Shupe, K, et al (1992) Chemotactic response of macrophages to Acanthamoeba castellanii antigen and antibody-dependent macrophage-mediated killing of the parasite J Parasitol 78,849-855[Medline][Order article via Infotrieve]
51. Stewart, GL, Shupe, K, Kim, I, et al (1994) Antibody-dependent neutrophil-mediated killing of Acanthamoeba castellanii Int J Parasitol 24,39-42
52. Martinez, AJ, Visvesvara, GS (1997) Free-living, amphizoic and opportunistic amebas Brain Pathol 7,583-598[Medline][Order article via Infotrieve]
53. Masihi, KN, Bhaduri, CR, Werner, H, Janitschke, K, Lange, W. (1986) Effects of muramyl dipeptide and trehalose dimycolate on resistance of mice to Toxoplasma gondii and Acanthamoeba culbertsoni Int Arch Allergy Appl Immunol 81,112-117[Medline][Order article via Infotrieve]
54. Van Klink, F, Taylor, WM, Alizadeh, H, Jager, MJ, van Rooijn, N, Niederkorn, JY (1996) The role of macrophages in Acanthamoeba keratitis Invest Ophthalmol Vis Sci 37,1271-1281[Abstract/Free Full Text]
55. Goulding, NJ, Euzger, HS, Butt, SK, Perretti, M. (1998) Novel pathways for glucocorticoid effects on neutrophils in chronic inflammation Inflamm Res 47(suppl 3),S158-S165
56. Markowitz, SM, Sobieski, T, Martinez, AJ, Duma, RJ (1978) Experimental Acanthamoeba infections in mice pre-treated with methylprednisolone or tetracycline Am J Pathol 92,733-741[Abstract]
57. Belayat, F, Meniai, K, Michaux, C, Kafidi, N, Coinoul, F, Dewaele, A. (1998) In vitro effect of glucocorticoids on phagocytic function of sheep alveolar macrophages Vet J 155,177-181[Medline][Order article via Infotrieve]
58. Metzger, Z, Berg, D, Dotan, M. (1997) Fibroblast growth in vitro is suppressed by LPS-activated macrophages: reversal of suppression by hydrocortisone J Endodontics 23,517-521[Medline][Order article via Infotrieve]

This article has been cited by other articles:

				M. Garate, H. Alizadeh, S. Neelam, J. Y. Niederkorn, and N. Panjwani Oral Immunization with Acanthamoeba castellanii Mannose-Binding Protein Ameliorates Amoebic Keratitis Infect. Immun., December 1, 2006; 74(12): 7032 - 7034. [Abstract] [Full Text] [PDF]

				D. W. Clarke, H. Alizadeh, and J. Y. Niederkorn Failure of Acanthamoeba castellanii to Produce Intraocular Infections Invest. Ophthalmol. Vis. Sci., July 1, 2005; 46(7): 2472 - 2478. [Abstract] [Full Text] [PDF]

				P P Syam, R Narendran, and J van der Hoek Persistent acanthamoeba keratitis in a non-contact lens wearer following exposure to bird seed dust Br. J. Ophthalmol., March 1, 2005; 89(3): 388 - 389. [Full Text] [PDF]

				F. Marciano-Cabral and G. Cabral Acanthamoeba spp. as Agents of Disease in Humans Clin. Microbiol. Rev., April 1, 2003; 16(2): 273 - 307. [Abstract] [Full Text] [PDF]

This Article Abstract Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire